Research Roundup

COPD treatments; celecoxib; HRT and risk of venous thromboembolism... Debbie Rigby takes a look at the latest in research news Dual combination therapy versus long‐acting bronchodilators alone for COPD A systematic review and network meta‐analysis of 99 studies (n=101,311) has concluded that LABA/LAMA combination bronchodilators reduce COPD exacerbations more than LABA/ICS combination, LAMA, and LABA

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Beyond the agreement
Next How many Australians are accessing unapproved medicinal cannabis?